News Conference News ACC 2018 Googling of Cardiac Symptoms Tracks With Hospital Admissions for Coronary Disease Yael L. Maxwell March 09, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Conference News ACC 2018 Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis Michael O'Riordan March 01, 2018
News Daily News Same-Same but Different: Young Women, Like Men, Report Chest Pain in Acute MI Michael O'Riordan February 23, 2018
News Daily News Low BP Tied to Poor Outcomes in Hospitalized Patients With HFpEF Todd Neale February 20, 2018
News Daily News One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL Michael O'Riordan February 12, 2018
News Daily News Heart Rate Changes Over Time Hint at Higher Cardiovascular Risk Michael O'Riordan January 25, 2018
News Daily News Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis Michael O'Riordan January 24, 2018
News Daily News High Rate of Clinical Events at 6 Months for Ischemic CVD Patients Michael O'Riordan January 19, 2018
News Daily News Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds Caitlin E. Cox January 18, 2018
News Daily News Women Have Higher Risk of Unplanned Readmission After PCI Michael O'Riordan January 12, 2018
News Daily News Cardiac Rehab Rates Still Low in Medicare and VA Populations L.A. McKeown January 09, 2018
News Daily News Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery Yael L. Maxwell January 09, 2018
News Daily News De-escalating DAPT to a Clopidogrel-Based Strategy After PCI for ACS Gets Boost in TOPIC-VASP Yael L. Maxwell January 04, 2018
News Daily News Hospital Mortality for Patients With A-fib Higher in Rural Areas Todd Neale December 11, 2017
News Daily News It’s Official: Evolocumab Gains Claim for CVD Event Reduction Michael O'Riordan December 04, 2017
News Conference News AHA 2017 Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events Michael O'Riordan November 17, 2017
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Conference News AHA 2017 Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI Yael L. Maxwell November 13, 2017